Endocr Metab Immune Disord Drug Targets
July 2024
Background: Type 2 Diabetes Mellitus (T2DM) represents a significant and pressing worldwide health concern, necessitating the quest for enhanced antidiabetic pharmaceuticals. Guanidine derivatives, notably metformin and buformin, have emerged as pivotal therapeutic agents for T2DM management.
Aims: The present study introduces an efficient one-pot synthesis method for the production of symmetrical guanidine compounds.